302 related articles for article (PubMed ID: 16699510)
1. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion.
Ding J; Guzman JN; Tkatch T; Chen S; Goldberg JA; Ebert PJ; Levitt P; Wilson CJ; Hamm HE; Surmeier DJ
Nat Neurosci; 2006 Jun; 9(6):832-42. PubMed ID: 16699510
[TBL] [Abstract][Full Text] [Related]
2. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.
Threlfell S; Clements MA; Khodai T; Pienaar IS; Exley R; Wess J; Cragg SJ
J Neurosci; 2010 Mar; 30(9):3398-408. PubMed ID: 20203199
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.
Wang Z; Kai L; Day M; Ronesi J; Yin HH; Ding J; Tkatch T; Lovinger DM; Surmeier DJ
Neuron; 2006 May; 50(3):443-52. PubMed ID: 16675398
[TBL] [Abstract][Full Text] [Related]
4. RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons.
Cabrera-Vera TM; Hernandez S; Earls LR; Medkova M; Sundgren-Andersson AK; Surmeier DJ; Hamm HE
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16339-44. PubMed ID: 15534226
[TBL] [Abstract][Full Text] [Related]
5. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
6. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
7. N-Ethylmaleimide differentiates between the M
Etscheid J; Mohr K; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1295-1299. PubMed ID: 30032313
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
10. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic Control of Striatal Cholinergic Interneurons Underlies Cocaine-Induced Psychostimulation.
Lewis RG; Serra M; Radl D; Gori M; Tran C; Michalak SE; Vanderwal CD; Borrelli E
Cell Rep; 2020 Apr; 31(3):107527. PubMed ID: 32320647
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
Drukarch B; Schepens E; Stoof JC
Neuroscience; 1990; 37(1):1-9. PubMed ID: 1978737
[TBL] [Abstract][Full Text] [Related]
13. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
Rubi L; Fritschy JM
J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
[TBL] [Abstract][Full Text] [Related]
14. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
[TBL] [Abstract][Full Text] [Related]
15. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
Tozzi A; de Iure A; Di Filippo M; Tantucci M; Costa C; Borsini F; Ghiglieri V; Giampà C; Fusco FR; Picconi B; Calabresi P
J Neurosci; 2011 Feb; 31(5):1850-62. PubMed ID: 21289195
[TBL] [Abstract][Full Text] [Related]
16. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
[TBL] [Abstract][Full Text] [Related]
17. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.
Nair AG; Castro LRV; El Khoury M; Gorgievski V; Giros B; Tzavara ET; Hellgren-Kotaleski J; Vincent P
Neuropharmacology; 2019 Mar; 146():74-83. PubMed ID: 30468798
[TBL] [Abstract][Full Text] [Related]
18. Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons.
Kharkwal G; Brami-Cherrier K; Lizardi-Ortiz JE; Nelson AB; Ramos M; Del Barrio D; Sulzer D; Kreitzer AC; Borrelli E
Neuron; 2016 Jul; 91(1):67-78. PubMed ID: 27387649
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
[TBL] [Abstract][Full Text] [Related]
20. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
Taymans JM; Leysen JE; Langlois X
J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
